|
Market Closed -
Saudi Arabian S.E.
08:35:50 2026-11-04 EST
|
5-day change | 1st Jan Change | ||
| 63.25 SAR | +3.27% |
|
+6.21% | -0.46% |
| 12:57am | Avalon Pharma's Q3 Attributable Net Profit, Revenue Rise | MT |
| 10-11 | Avalon Pharma Signs 10-year Licensing Agreement With OneSource Specialty Pharma | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.27% | +6.21% | +1.69% | +8.49% | -0.46% | -16.15% | - | - | - | 571M | |
| +1.58% | +11.03% | +25.13% | +28.21% | +33.10% | +57.73% | +140.32% | +427.81% | +1,873.18% | 1,255B | |
| +2.86% | +0.38% | +7.57% | +6.73% | +31.47% | +45.60% | +79.35% | +65.29% | +136.36% | 641B | |
| +1.37% | +0.92% | +8.60% | +18.38% | +26.31% | +33.68% | +104.40% | +146.55% | +415.01% | 505B | |
| +1.25% | -0.73% | +13.47% | +10.68% | +20.63% | +49.96% | +66.94% | +6.91% | +79.87% | 381B | |
| +2.45% | +5.05% | +6.09% | +15.66% | +40.64% | +76.53% | +41.88% | +63.51% | +151.68% | 357B | |
| +2.10% | +3.90% | +15.26% | +7.75% | +22.50% | +32.30% | +59.38% | +75.89% | +97.01% | 303B | |
| +1.92% | +9.87% | +19.21% | +19.45% | +1.70% | +11.94% | +36.47% | +48.51% | +221.06% | 286B | |
| +3.58% | +5.77% | +18.59% | +22.53% | +46.01% | +61.07% | +75.16% | +122.35% | +252.95% | 249B | |
| +3.79% | +8.72% | +19.68% | +27.98% | +41.02% | +40.72% | +113.32% | +160.40% | +138.98% | 208B | |
| +5.57% | +11.84% | +15.56% | -7.28% | -12.31% | -9.52% | -59.32% | -23.41% | +148.76% | 179B | |
| +1.72% | +3.55% | +11.26% | +20.01% | +22.47% | +25.49% | -2.20% | -30.46% | +1.65% | 171B | |
| +2.95% | +2.88% | +8.23% | +13.84% | +20.20% | +29.23% | +41.26% | +180.59% | +590.15% | 135B | |
| +2.34% | +3.91% | +7.02% | -4.48% | +16.69% | +38.06% | +19.23% | +6.23% | +23.39% | 126B | |
| +2.93% | +6.86% | +12.13% | +23.61% | +25.14% | +21.96% | +123.15% | +360.12% | +685.02% | 117B | |
| +3.85% | +11.38% | +20.16% | +13.05% | +1.67% | -2.56% | -0.99% | -6.23% | +17.52% | 109B | |
| +3.42% | +3.19% | +7.45% | -1.28% | +3.59% | +5.62% | +34.52% | -3.72% | -1.08% | 98.3B | |
| -2.33% | +17.28% | +31.29% | +25.39% | +23.57% | +51.87% | +14.58% | +47.27% | +179.38% | 97.67B | |
| +8.54% | +16.80% | +23.10% | +338.94% | +748.25% | +953.26% | +247.09% | -11.93% | - | 91.2B | |
| +0.87% | +3.01% | +10.58% | +2.80% | +22.72% | +33.50% | +2.63% | -30.57% | +65.02% | 72.58B | |
| Average | +2.63% | +3.85% | +14.10% | +29.52% | +56.74% | +77.02% | +59.85% | +84.48% | +281.99% | 269.05B | |
| Weighted average by Cap. | +2.21% | +4.01% | +15.58% | +22.13% | +38.43% | +57.72% | +79.86% | +155.55% | +591.95% |
- Stock Market
- Stocks
- 4016 Stock
- Sector Middle East Pharmaceutical Industries Company
Select your edition
All financial news and data tailored to specific country editions
